Literature DB >> 23674173

Reply to Townsend et al.

Carmen Ayuso1, José M Millán2, Marta Mancheño3, Rafael Dal-Ré4.   

Abstract

Mesh：

Year:  2013        PMID： 23674173      PMCID： PMC3865417          DOI： 10.1038/ejhg.2013.95

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  4 in total

1.  Autonomy and the patient's right 'not to know' in clinical whole-genomic sequencing.

Authors:  Anne Townsend; Francois Rousseau; Jan Friedman; Shelin Adam; Zoe Lohn; Patricia Birch
Journal:  Eur J Hum Genet       Date:  2013-05-15       Impact factor: 4.246

2.  Exome sequencing can improve diagnosis and alter patient management.

Authors:  Stacey B Gabriel; Joseph G Gleeson; Tracy J Dixon-Salazar; Jennifer L Silhavy; Nitin Udpa; Jana Schroth; Stephanie Bielas; Ashleigh E Schaffer; Jesus Olvera; Vineet Bafna; Maha S Zaki; Ghada H Abdel-Salam; Lobna A Mansour; Laila Selim; Sawsan Abdel-Hadi; Naima Marzouki; Tawfeg Ben-Omran; Nouriya A Al-Saana; F Müjgan Sonmez; Figen Celep; Matloob Azam; Kiley J Hill; Adrienne Collazo; Ali G Fenstermaker; Gaia Novarino; Naiara Akizu; Kiran V Garimella; Carrie Sougnez; Carsten Russ
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

3.  Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process.

Authors:  Carmen Ayuso; José M Millán; Marta Mancheño; Rafael Dal-Ré
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

4.  Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time.

Authors:  Jonathan S Berg; Muin J Khoury; James P Evans
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.